Status:

COMPLETED

Digital Fall Prevention Study

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

Best Buy Health, Inc

Conditions:

Fall

Eligibility:

All Genders

65+ years

Phase:

PHASE1

PHASE2

Brief Summary

The Digital Fall Prevention Study is a single-group unblinded study to explore the feasibility and acceptability of a 3-month fall prevention exercise program delivered digitally via a tablet interfac...

Detailed Description

The goal of this study is to demonstrate the feasibility and acceptability of a digital fall prevention exercise program and to explore whether there is benefit from participating in such programs. Th...

Eligibility Criteria

Inclusion

  • Male and females who are 65 years or older
  • Short Physical Performance Battery (SPPB)7 ≥ 5
  • the Montreal Cognitive Assessment (MoCA)8 \> 17
  • Increased risk for falls based on a self-reported answer of yes to one or more of these questions:
  • Have you fallen and hurt yourself in the past year?
  • Have you fallen two or more times in the past year?
  • Are you afraid that you might fall because of balance or walking problems?
  • Access to Wi-Fi in their home (or willingness to use cellular service if provided)

Exclusion

  • Unable or unwilling to provide informed consent
  • MI, acute coronary syndrome, revascularization surgery, or stroke in the last 6 months
  • Chest pain or untreated/uncontrolled CVD
  • Hip/knee fracture/replacement or spinal surgery in past 6 months
  • Pulmonary decompensation that would prevent participation in the exercise program
  • Planned orthopedic surgery that would limit participation in the study
  • Planned to be away from tablet access for \> 7 days during the length of the study
  • Unable to attend in-person pre- or post-study clinic visit
  • Enrolled in a formal exercise program and/or physical therapy that takes place 3 or more times per week
  • Vision or hearing impairments that would make it difficult to participate in the intervention
  • Non-English speaking or other language limitations that would make it difficult to participate in the intervention
  • Reside in a nursing home
  • Unable to walk independently (with or without a walking aid)
  • Not appropriate for study based on clinician exam or discretion (clinician will specify reason)

Key Trial Info

Start Date :

June 30 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2023

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT05432674

Start Date

June 30 2022

End Date

June 1 2023

Last Update

July 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115